Hexarelin

A synthetic hexapeptide growth hormone secretagogue related to GHRP-6, studied in human endocrine research.

What research shows

Hexarelin has real human pharmacology from the 1990s: dose-response studies show it raises growth hormone, and reviews describe cardiovascular effects seen in experimental work. Modern outcome data is absent. Nothing we verified addresses muscle, fat or recovery in healthy people.

Evidence strength

Highest evidence grade among the graded claims: B. Grades reflect study strength, not benefit.

Safety context

See the safety section. Absence of a flag is not evidence of safety.

No endorsement

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.